ConductScience.org, home

Paper32207688

2019 Expert opinion on biological treatment use in inflammatory bowel disease management.

Törüner M and 8 others. Turk J Gastroenterol, 2019. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management. Papers, record 32207688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32207688

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
2019 Expert opinion on biological treatment use in inflammatory bowel disease management.
PubMed
Journal
Turk J Gastroenterol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2024-12-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Törüner MMurat
2Akpınar HHale
3Akyüz FFiliz
4Dağlı ÜÜlkü
5Över Hamzaoğlu HHülya
6Tezel AAhmet
7Ünsal BBelkıs
8Yıldırım SSüleyman
9Çelik AFAykut Ferhat

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Colitis, UlcerativeMajor topic
Crohn DiseaseMajor topic
Gastrointestinal AgentsMajor topic
Inflammatory Bowel DiseasesMajor topic
Disease Management
Humans
Practice Guidelines as Topic

Source PubMed

Download CSV of topics

References213

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121407188Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.Am J Gastroenterol2011https://conductscience.org/library/papers/21407188PubMed
224641622Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.Aliment Pharmacol Ther2014https://conductscience.org/library/papers/24641622PubMed
39510317Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.Dis Colon Rectum1998https://conductscience.org/library/papers/9510317PubMed
418727929Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.Gastroenterology2008https://conductscience.org/library/papers/18727929PubMed
519821389Interventions for prevention of post-operative recurrence of Crohn's disease.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19821389PubMed
622890223Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.Am J Gastroenterol2012https://conductscience.org/library/papers/22890223PubMed
730543573Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.Eur J Gastroenterol Hepatol2019https://conductscience.org/library/papers/30543573PubMed
821122553European evidenced-based consensus on reproduction in inflammatory bowel disease.J Crohns Colitis2010https://conductscience.org/library/papers/21122553PubMed
918242053Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.Reprod Toxicol2008https://conductscience.org/library/papers/18242053PubMed
1027579102Is breastfeeding safe with azathioprine?Obstet Med2011https://conductscience.org/library/papers/27579102PubMed
1121209123Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.Gut2011https://conductscience.org/library/papers/21209123PubMed
1229682686Resolution of Metastatic Colon Cancer upon Withdrawal of Anti-TNF Therapy for Crohn's Disease.J Gastrointest Cancer2019https://conductscience.org/library/papers/29682686PubMed
1316678077Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16678077PubMed
1428158411The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.J Crohns Colitis2017https://conductscience.org/library/papers/28158411PubMed
1523897285IBD medications during pregnancy and lactation.Nat Rev Gastroenterol Hepatol2014https://conductscience.org/library/papers/23897285PubMed
1622062358Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.Gastroenterology2012https://conductscience.org/library/papers/22062358PubMed
1722530631Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.Aliment Pharmacol Ther2012https://conductscience.org/library/papers/22530631PubMed
187797011Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).Gastroenterology1995https://conductscience.org/library/papers/7797011PubMed
1929317275
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
Gastroenterology2018https://conductscience.org/library/papers/29317275PubMed
2020055530Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development.BioDrugs2010https://conductscience.org/library/papers/20055530PubMed

See all 213 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
35726844Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.Turk J Gastroenterol2022https://conductscience.org/library/papers/35726844PubMed
34405814Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.Turk J Gastroenterol2021https://conductscience.org/library/papers/34405814PubMed
32774388
Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23.
Case Rep Med2020https://conductscience.org/library/papers/32774388PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32207688

GET https://conductscience.org/api/papers/v1/32207688/references?page=2